AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) Launches Aurora Envoy Transporter

AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) Launches Aurora Envoy Transporter

SHARE

AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) has seen a 20 cent jump in price this week. Investors must be pleased with this Canadian cannabis giant. ACBFF has risen from $1.86 at the start of the year to now $2.45.

ACBFF just also launched its Aurora Envoy product that is geared toward home growers. The patented Envoy is a live plant transporter. According to the company, the Aurora Envoy possesses several novel and inventive features that promote the health, vigor and vegetative growth of live plant cuttings during shipment, leading to high transplant success rates and an exceptional customer experience.

AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) is a licensed producer of medical marijuana pursuant to the Marijuana for Medical Purposes Regulations and operates a 55,200 square foot expandable state-of-the-art production facility in Alberta, Canada.

ACBFF’s wholly-owned subsidiary, Australis Capital Inc., seeks to be an active participant in the U.S. Cannabis market. Aurora is trading on the Canadian Securities Exchange under the trading symbol “ACB”. The company is headquartered in Vancouver, Canada.

According to company’s materials, “Aurora’s wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”). The Company operates a 55,200 square foot, state-of-the-art production facility in Mountain View County, Alberta, is currently constructing a second 800,000 square foot production facility, known as “Aurora Sky”, at the Edmonton International Airport, and has acquired, and is undertaking completion of a third 40,000 square foot production facility in Pointe-Claire, Quebec, on Montreal’s West Island. In addition, the Company holds approximately 9.6% of the issued shares (12.9% on a fully-diluted basis) in leading extraction technology company Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based Hempco Food and Fiber for an ownership stake of up to 50.1%. Furthermore, Aurora is the cornerstone investor with a 19.9% stake in Cann Group Limited, the first Australian company licensed to conduct research on and cultivate medical cannabis. Aurora also owns Pedanios, a leading wholesale importer, exporter, and distributor of medical cannabis in the European Union (“EU”), based in Germany.”

Find out when $ACBFF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Neil Belot, Chief Global Business Development Officer for Aurora, added, “Our team looked at all available options on the market. We were unable to find one that met the Aurora Standard, and consequently we developed our own. Following months of thorough testing and design iterations, we are proud to say that no other comparable product on the market today offers the same level of technological sophistication as the Aurora Envoy. We employ one of the best and brightest industrial designers in this industry, and with the support of our exceptional team, we have once again set a new standard for the cannabis industry.”

“The Envoy brings together our guiding principle of patients-first with our ongoing support of peoples’ ability to make the choice to grow at home,” said Terry Booth , CEO. “The Envoy is therefore the perfect complement to our home garden offering through BC Northern Lights, which we recently acquired. Enabling people to grow at home, to achieve higher success rates and produce exceptional yields while effectively addressing all of the issues previously raised by the public and municipal governments, is a huge step forward in helping to build this important segment of the cannabis industry.”

Currently trading at a market capitalization of $917.29M, ACBFF is pulling in trailing 12-month revenues of $13.4M. The company should also start to see improved revenues on the launch of the Envoy.  Already, the company is seeing major top-line growth, with y/y quarterly revenues growing at 2260.7%. This may be a very interesting story and we will look forward to updating it again soon. Sign-up for continuing coverage on shares of $ACBFF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: We hold no position in $ACBFF, either long or short, and we have not been compensated for this article.

Sign Up for our 100% FREE Oracle Dispatch Newsletter